Quantification of insulin receptor mRNA splice variants as a diagnostic tumor marker in breast cancer

Abstract

The results demonstrate an increased IR-A:IR-B ratio in all clinical stages of breast cancer. Thus, IR-A:IR-B ratio may have a diagnostic biomarker utility in breast cancer.